Multiplex Assay Kit for A Disintegrin And Metalloprotease 10 (ADAM10) ,etc. by FLIA (Flow Luminescence Immunoassay)

CD156-C; CD156c; MADM; Kuz; CDw156; Kuzbanian protein homolog; Mammalian disintegrin-metalloprotease

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of A Disintegrin And Metalloprotease 10 (ADAM10) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between A Disintegrin And Metalloprotease 10 (ADAM10) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant A Disintegrin And Metalloprotease 10 (ADAM10) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of A Disintegrin And Metalloprotease 10 (ADAM10) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 82-101 88
EDTA plasma(n=5) 85-101 96
heparin plasma(n=5) 96-104 101

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level A Disintegrin And Metalloprotease 10 (ADAM10) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level A Disintegrin And Metalloprotease 10 (ADAM10) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of A Disintegrin And Metalloprotease 10 (ADAM10) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 79-93% 84-93% 78-96% 98-105%
EDTA plasma(n=5) 87-98% 87-99% 82-91% 81-92%
heparin plasma(n=5) 88-97% 88-97% 78-89% 92-105%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:ADAM10) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Journal of Allergy and Clinical Immunology RAGE processing in chronic airway conditions: Involvement of Staphylococcus aureus and ECP ScienceDirect: S0091674912003508
British journal of cancer ADAM10: a new player in breast cancer progression? PubMed: 26284334
Int Wound J. From varices to venous ulceration: the story of chronic venous disease described by metalloproteinases. Pubmed:26991748
International Wound Journal From varices to venous ulceration: the story of chronic venous disease described by metalloproteinases pubmed:26991748
Disease Markers Adamalysines as Biomarkers and a Potential Target of Therapy in Colorectal Cancer Patients: Preliminary Results Pubmed: 31565100
ADAM10 Plasma Levels Predict Worsening in Cognition of Older Adults: A 3-Year Follow-Up Study
Alzheimers Research & Therapy ADAM10 plasma levels predict worsening in cognition of older adults: a 3-year follow-up study. 33419480
life High Levels of TNF-¦Á and TIM-3 as a Biomarker of Immune Reconstitution Inflammatory Syndrome in People with HIV Infection
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPA766Hu01 Recombinant A Disintegrin And Metalloprotease 10 (ADAM10) Positive Control; Immunogen; SDS-PAGE; WB.
EPA766Hu62 Eukaryotic A Disintegrin And Metalloprotease 10 (ADAM10) Positive Control; Immunogen; SDS-PAGE; WB.
EPA766Hu61 Eukaryotic A Disintegrin And Metalloprotease 10 (ADAM10) Positive Control; Immunogen; SDS-PAGE; WB.
PAA766Hu01 Polyclonal Antibody to A Disintegrin And Metalloprotease 10 (ADAM10) WB; IHC; ICC; IP.
FAA766Hu01 Anti-A Disintegrin And Metalloprotease 10 (ADAM10) Polyclonal Antibody Flow cytometry.
LAA766Hu71 Biotin-Linked Polyclonal Antibody to A Disintegrin And Metalloprotease 10 (ADAM10) WB; IHC; ICC.
MAA766Hu22 Monoclonal Antibody to A Disintegrin And Metalloprotease 10 (ADAM10) WB; IHC; ICC; IP.
SEA766Hu ELISA Kit for A Disintegrin And Metalloprotease 10 (ADAM10) Enzyme-linked immunosorbent assay for Antigen Detection.
LMA766Hu Multiplex Assay Kit for A Disintegrin And Metalloprotease 10 (ADAM10) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.